Harel Insurance Investments & Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Hold	198	–	–	﹤0.01%	498
2026 Q1	$16K	Hold	198	–	–	﹤0.01%	478
2025 Q4	$16K	Hold	198	–	–	﹤0.01%	399
2025 Q3	$12K	Hold	198	–	–	﹤0.01%	442
2025 Q2	$9K	Hold	198	–	–	﹤0.01%	407
2025 Q1	$10K	Hold	198	–	–	﹤0.01%	436
2024 Q4	$10K	Hold	198	–	–	﹤0.01%	424
2024 Q3	$13K	Hold	198	–	–	﹤0.01%	438
2024 Q2	$12K	Hold	198	–	–	﹤0.01%	470
2024 Q1	$11K	Hold	198	–	–	﹤0.01%	475
2023 Q4	$11K	Hold	198	–	–	﹤0.01%	530
2023 Q3	$9K	Buy	+198	New	+$10.2K	﹤0.01%	599

Other funds holding BIB

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

Harel Insurance Investments & Financial Services's BIB Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q2 2026 at 198 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Harel Insurance Investments & Financial Services first reported a position in BIB in Q3 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

Harel Insurance Investments & Financial Services held 198 shares of ProShares Ultra NASDAQ Biotechnology worth $20K as of Q2 2026.
Harel Insurance Investments & Financial Services left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q2 2026.
ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #498 holding.
Harel Insurance Investments & Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2023 and has held it in 12 quarters since.
8 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.